FDA rehires some laid-off staff, though some fear lasting damage to trust
Regulatory NewsFerdous Al-Faruque
Biologics/ biosimilars/ vaccinesGovernment/legislationMedical DevicesPharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)